You are here

Article info

Article menu
Download PDFPDF
Original research
Levetiracetam pharmacokinetics and its covariates: proposal for optimal dosing in the paediatric population

Authors

  • Pavla Pokorná Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic Department of Physiology and Pharmacology, Karolinska University Hospital, Stockholm, Sweden Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic Intensive Care and Department of Pediatric Surgery, Erasmus University Medical Center – Sophia Children's Hospital, Rotterdam, Netherlands PubMed articlesGoogle scholar articles
  • Martin Šíma Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • Natálie Švestková Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • Ondřej Slanař Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Martin Šíma, Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 00 Prague, Czech Republic; martin.sima{at}lf1.cuni.cz
View Full Text

Citation

Pokorná P, Šíma M, Švestková N, et al
Levetiracetam pharmacokinetics and its covariates: proposal for optimal dosing in the paediatric population
European Journal of Hospital Pharmacy 2023;30:359-362.

Publication history

  • Received September 14, 2021
  • Accepted October 26, 2021
  • First published November 9, 2021.
Online issue publication 
February 06, 2024

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© European Association of Hospital Pharmacists 2023. No commercial re-use. See rights and permissions. Published by BMJ.